1. Signaling Pathways
  2. Immunology/Inflammation
  3. Interleukin Related
  4. IL-5 Isoform
  5. IL-5 Antagonist

IL-5 Antagonist

IL-5 Antagonist (1):

Cat. No. Product Name Effect Purity
  • HY-P9949
    Antagonist 99.40%
    Reslizumab (Sch 55700) is humanized monoclonal antibodies that target interleukin-5 (IL-5) for the treatment of eosinophilic asthma. Reslizumab is effective in neutralizing the function of IL-5. Reslizumab has high binding affinity for human IL-5, with KD values of 109 pM and 4.3 pM in the the Biacore surface plasmon resonance and Kinetic Exclusion Assay, respectively.